ArticleScientific reports2025
Respiratory tract infections at the Grand Magal de Touba: a seven-year study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Grand Magal of Touba (GMT) is the largest religious gathering in West Africa, and, like any large mass gathering, presents a risk of transmission of infectious diseases, mainly respiratory tract infections. Respiratory pathogen carriage was assessed by qPCR between 2017 and 2023 in healthy and ill pilgrims. The study included 1067 pilgrims comprizing 328 healthy controls, 298 pilgrims with respiratory symptoms who did not consult and 441 patients who consulted for respiratory symptoms. Among healthy controls, 7% tested positive for rhinovirus, 4% for endemic coronaviruses, 45% for Haemophilus spp. and 29% for Staphylococcus aureus. Among non-consulting ill pilgrims, 14% tested positive for rhinovirus, 8% for endemic coronaviruses, 45% for Haemophilus spp., 31% for S. aureus and 32% for Streptococcus pneumoniae. Among consulting patients, 29% tested positive for influenza A, 14% for respiratory syncytial virus, 9% for rhinovirus, 62% for Haemophilus spp., 47% for S. pneumoniae and 39% for Moraxella catarrhalis. Co-infection with viruses and bacteria was 12% in healthy controls, 23% in non-consulting ill pilgrims and 51% in consulting patients. Female gender was independently associated with a higher risk for respiratory symptoms. Symptomatic individuals were 53 times more likely to test positive for influenza A virus, 2 times for S. pneumoniae and M. catarrhalis and 3 times more likely to have a bacteria-virus co-infection. When comparing non-consulting ill pilgrims and consulting patients, the latter were 29 times more likely to test positive for influenza B virus, 16 times for respiratory syncytial virus, 14 times for influenza A virus and 3 times for M. catarrhalis. Influenza virus, respiratory syncytial virus, S. pneumoniae and M. catarrhalis could play a major role in the pathogenesis of respiratory infections at the GMT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.